Download PDF
Thromb Haemost 1995; 73(03): 555-556
DOI: 10.1055/s-0038-1653819
Letters to the Editor
Schattauer GmbH Stuttgart

Parvovirus B19 Antibodies in Patients with Haemophilia A

K Peerlinck
Center for Molecular and Vascular Biology, Rega Institute and University Hospitals of Leuven, Leuven, Belgium
,
P Goubau
1   Department of Microbiology, Rega Institute and University Hospitals of Leuven, Leuven, Belgium
,
R Reybrouck
1   Department of Microbiology, Rega Institute and University Hospitals of Leuven, Leuven, Belgium
,
J Desmyter
1   Department of Microbiology, Rega Institute and University Hospitals of Leuven, Leuven, Belgium
,
J Vermylen
Center for Molecular and Vascular Biology, Rega Institute and University Hospitals of Leuven, Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Received 10 November 1994

Accepted after revision 29 November 1994

Publication Date:
26 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Große-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE. Serological and virological markers of human Parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost 1994; 72: 503-507
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Mortimer PP, Luban NL C, Kelleher JF, Cohen BJ. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 1983; 2: 482-484
    PubMedGoogle Scholar
  • 3 Bartolomei CorsiO, Azzi A, Morfini M, Fanci R, Rossi FerriniP. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165-170
    CrossrefPubMedGoogle Scholar
  • 4 Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 1991; 23: 675-679
    CrossrefPubMedGoogle Scholar
  • 5 Azzi A, Ciappi S, Zakvrzewska K, Morfini M, Mariani G, Mannucci PM. Human parvovirus B19 infection in hemophiliacs first infused with two- high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992; 30: 228-230
    PubMedGoogle Scholar
  • 6 Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M. Eliminating parvovirus B19 from blood products. Lancet 1994; 343: 798 (Letter)
    PubMedGoogle Scholar
  • 7 Brown CS, Van BusselM, Wassenaar AL, Van Elsacker-Niele AM, Weiland HT, Salimans MM. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. J Virol Methods 1990; 29: 53-62
    CrossrefPubMedGoogle Scholar